Publication | Closed Access

Long-term persistence of anti-HPV-16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: Modeling of sustained antibody responses☆

Vaccination-18 AntibodiesAntibody Responses☆Cervical CancerVaccine DevelopmentHuman Papillomavirus VaccinesMedicineImmunologyVaccine TestingVaccine DesignImmunotherapyLong-term PersistenceVaccine ResearchViral Immunity